• Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InVivo Therapeutics Holdings Corp

+ Add to Watchlist

O4I:GR

1.168 EUR 0.333 39.88%

As of 11:14:11 ET on 12/19/2014.

Snapshot for InVivo Therapeutics Holdings Corp (O4I)

Open: 0.923 Day's Range: 0.922 - 1.168 Volume: 1,065
Previous Close: 0.835 52wk Range: 0.341 - 1.980 1-Yr Rtn: -13.16%

Stock Chart for O4I

No chart data available.
  • O4I:GR 1.168
  • 1D
  • 1M
  • 1Y
0.835
Interactive O4I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for O4I

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2000
Est. PEG Ratio -
Market Cap (M EUR) 109.26
Shares Outstanding (M) 93.55
30 Day Average Volume 1,208
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for O4I

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for O4I

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Mark D PerrinChief Executive OfficerSteven McAllister "Steve"Chief Financial Officer
Thomas R UlichChief Scientific OfficerTamara L JosephSenior VP/Chief Compliance Ofcr
More Company Profile & Key Executives for O4I

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil